T-Cypher Bio
Samhita Rao is a Senior Scientist at T-Cypher Bio since September 2022. Prior to this role, Samhita held positions at Columbia University Irving Medical Center as a Doctoral Student, Stanford University School of Medicine as a Life Science Research Professional, University of Illinois Chicago as a Research Specialist, and University of Pennsylvania as a Research Specialist. Samhita earned a PhD in Microbiology, Immunology and Infection from Columbia University, a Master of Biotechnology in Molecular Biology from the University of Pennsylvania, and a Bachelor of Pharmacy in Pharmaceutical Sciences from the University of Mumbai.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.